Evidence map›Paper›PMID 24090766›Full record

ArticleNeuropharmacology2014

ΔFosB induction correlates inversely with CB₁ receptor desensitization in a brain region-dependent manner following repeated Δ⁹-THC administration.

Matthew F Lazenka, Dana E Selley, Laura J Sim-Selley

Open access · greenAbstract read
In one paragraph

Article in Neuropharmacology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
3.8field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 28 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. ΔAddiction biology · 2023
    Article
  6. Voluntary oral consumption of ΔNeuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2019
    Article
  7. ΔCannabis and cannabinoid research · 2017
    Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Matthew F LazenkaDepartment of Pharmacology and Toxicology, Institute for Drug and Alcohol Studies, Virginia Commonwealth University, Richmond, VA, USA.
Dana E SelleyDepartment of Pharmacology and Toxicology, Institute for Drug and Alcohol Studies, Virginia Commonwealth University, Richmond, VA, USA.
Laura J Sim-SelleyDepartment of Pharmacology and Toxicology, Institute for Drug and Alcohol Studies, Virginia Commonwealth University, Richmond, VA, USA. Electronic address: ljsimsel@vcu.edu.
Virginia Commonwealth University · US

Funding

TRAINING IN THE PHARMACOLOGY OF ABUSED DRUGST32DA007027 · NIDA · VIRGINIA COMMONWEALTH UNIVERSITY · PI William L. Dewey · 1985 to 2026
$14.7M
VCU Center for Drug Addiction ResearchP30DA033934 · NIDA · VIRGINIA COMMONWEALTH UNIVERSITY · PI Sidney S Negus · 2014 to 2026
$13.8M
VCU Neuroscience Center Core GrantP30NS047463 · NINDS · VIRGINIA COMMONWEALTH UNIVERSITY · PI POVLISHOCK, JOHN T · 2003 to 2013
$5.0M
Neuronal cannabinoidsR01DA011322 · NIDA · UNIVERSITY OF WASHINGTON · PI MACKIE, KENNETH · 1998 to 2014
$3.4M
Brain Cannabinoid Signaling: Selectivity and AdaptationR01DA014277 · NIDA · VIRGINIA COMMONWEALTH UNIVERSITY · PI SIM-SELLEY, LAURA J · 2002 to 2010
$1.7M
Cannabinoid Modulation of Cell FunctionK05DA021696 · NIDA · TRUSTEES OF INDIANA UNIVERSITY · PI MACKIE, KENNETH · 2007 to 2017
$1.3M
CB1 Receptor Regulation by Cannabinoid Receptor Interacting Protein CRIP1aR21DA025321 · NIDA · VIRGINIA COMMONWEALTH UNIVERSITY · PI HOWLETT, ALLYN C, SELLEY, DANA E · 2009 to 2010
$420k
Regulation of striatal cannabinoid CB1 receptors by DARPP32 and deltaFosB mediateF31DA030227 · NIDA · VIRGINIA COMMONWEALTH UNIVERSITY · PI LAZENKA, MATTHEW F · 2011 to 2012
$67k
NIDA NIH HHS DA011322NIDA NIH HHS DA014277NIDA NIH HHS DA021696NIDA NIH HHS DA025321NIDA NIH HHS F31 DA030227NIDA NIH HHS F31-DA030227NIDA NIH HHS K05 DA021696NIDA NIH HHS P30 DA033934NIDA NIH HHS R01 DA011322NIDA NIH HHS R01 DA014277NIDA NIH HHS R21 DA025321NIDA NIH HHS T32 DA007027NINDS NIH HHS 5P30NS047463NINDS NIH HHS P30 NS047463
6 · The paper itself

Abstract

Repeated Δ(9)-tetrahydrocannabinol (THC) administration produces desensitization and downregulation of cannabinoid type 1 receptors (CB₁Rs) in the brain, but the magnitude of these adaptations varies among regions. CB₁Rs in the striatum and its output regions exhibit the least magnitude and slowest development of desensitization and downregulation. The molecular mechanisms that confer these region-dependent differences are not known. The stable transcription factor, ΔFosB, is induced in the striatum following repeated THC administration and could regulate CB₁Rs. To directly compare the regional profile of ΔFosB induction and CB₁R desensitization and downregulation, mice were treated with THC (10 mg/kg) or vehicle for 13.5 days. CP55,940-stimulated [(35)S]GTPγS autoradiography and immunohistochemistry were performed to measure CB₁R desensitization and downregulation, respectively, and ΔFosB expression was measured by immunoblot. Significant CB₁R desensitization and downregulation occurred in the prefrontal cortex, lateral amygdala and hippocampus; desensitization was found in the basomedial amygdala and no changes were seen in remaining regions. ΔFosB was induced in the prefrontal cortex, caudate-putamen, nucleus accumbens and lateral amygdala. An inverse regional relationship between ΔFosB expression and CB₁R desensitization was found, such that regions with the greatest ΔFosB induction did not exhibit CB₁R desensitization and areas without ΔFosB induction had the greatest desensitization, with remaining regions exhibiting intermediate levels of both. Dual immunohistochemistry in the striatum showed both CB₁R co-localization with ΔFosB in cells and CB₁R puncta surrounding ΔFosB-positive cells. THC-induced expression of ΔFosB was absent in the striatum of CB₁R knockout mice. These data suggest that transcriptional targets of ΔFosB might inhibit CB₁R desensitization and/or that ΔFosB induction could be limited by CB₁R desensitization.

Indexed as

AnimalsBrainCorpus StriatumDown-RegulationDronabinolGuanosine 5'-O-(3-Thiotriphosphate)MaleMiceMice, Inbred ICRMice, KnockoutProto-Oncogene Proteins c-fosReceptor, Cannabinoid, CB1DronabinolFosb protein, mouseGuanosine 5'-O-(3-Thiotriphosphate)Proto-Oncogene Proteins c-fosReceptor, Cannabinoid, CB1CannabinoidCaudate-putamenG-proteinHippocampusNucleus accumbens

Identifiers

PMID24090766
PMCPMC3888085
OpenAlexW1976525000

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.